DrugCite
Search

HYDROCORTISONE SODIUM SUCCINATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Hydrocortisone Sodium Succinate Adverse Events Reported to the FDA Over Time

How are Hydrocortisone Sodium Succinate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Hydrocortisone Sodium Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Hydrocortisone Sodium Succinate is flagged as the suspect drug causing the adverse event.

Most Common Hydrocortisone Sodium Succinate Adverse Events Reported to the FDA

What are the most common Hydrocortisone Sodium Succinate adverse events reported to the FDA?

Dyspnoea
45 (1.92%)
Shock
42 (1.79%)
Anaphylactic Shock
33 (1.41%)
Pyrexia
32 (1.37%)
Pneumonia
27 (1.15%)
Drug Ineffective
24 (1.02%)
Nausea
24 (1.02%)
Urticaria
24 (1.02%)
Hypersensitivity
22 (.94%)
Hypotension
22 (.94%)
Respiratory Failure
21 (.9%)
Show More Show More
Reversible Posterior Leukoencephalo...
21 (.9%)
Convulsion
20 (.85%)
Infusion Related Reaction
20 (.85%)
Blood Glucose Increased
19 (.81%)
Flushing
18 (.77%)
Loss Of Consciousness
18 (.77%)
Vomiting
18 (.77%)
Blood Pressure Decreased
17 (.73%)
Blood Pressure Increased
17 (.73%)
Septic Shock
17 (.73%)
Anaemia
16 (.68%)
Condition Aggravated
16 (.68%)
Diarrhoea
16 (.68%)
Platelet Count Decreased
16 (.68%)
Anaphylactic Reaction
15 (.64%)
Asthma
15 (.64%)
Malaise
13 (.56%)
Abdominal Pain
12 (.51%)
Disorientation
12 (.51%)
Hyperglycaemia
12 (.51%)
Hyperhidrosis
12 (.51%)
Osteonecrosis
12 (.51%)
Pleural Effusion
12 (.51%)
Stevens-johnson Syndrome
12 (.51%)
Acute Respiratory Distress Syndrome
11 (.47%)
Agitation
11 (.47%)
Deep Vein Thrombosis
11 (.47%)
Erythema
11 (.47%)
Pulmonary Oedema
11 (.47%)
Tachycardia
11 (.47%)
Thrombocytopenia
11 (.47%)
Cough
10 (.43%)
Febrile Neutropenia
10 (.43%)
Hypertension
10 (.43%)
Infection
10 (.43%)
Paraesthesia
10 (.43%)
Renal Failure Acute
10 (.43%)
Sepsis
10 (.43%)
Adrenocortical Insufficiency Acute
9 (.38%)
Dysphagia
9 (.38%)
Heparin-induced Thrombocytopenia
9 (.38%)
Hepatic Function Abnormal
9 (.38%)
Histiocytosis Haematophagic
9 (.38%)
Hypokalaemia
9 (.38%)
Oedema
9 (.38%)
Pruritus
9 (.38%)
Ventricular Extrasystoles
9 (.38%)
Anaphylactoid Reaction
8 (.34%)
Aspartate Aminotransferase Increase...
8 (.34%)
Blood Lactic Acid Decreased
8 (.34%)
Blood Pressure Systolic Increased
8 (.34%)
Dehydration
8 (.34%)
Gastrointestinal Haemorrhage
8 (.34%)
Hepatosplenomegaly
8 (.34%)
Hypoaesthesia
8 (.34%)
Leukopenia
8 (.34%)
Medication Error
8 (.34%)
Multi-organ Failure
8 (.34%)
Muscular Weakness
8 (.34%)
Pain
8 (.34%)
Pancytopenia
8 (.34%)
Alanine Aminotransferase Increased
7 (.3%)
Breath Sounds Abnormal
7 (.3%)
Cardiomegaly
7 (.3%)
Chest Discomfort
7 (.3%)
Delirium
7 (.3%)
Depressed Level Of Consciousness
7 (.3%)
Disseminated Intravascular Coagulat...
7 (.3%)
Drug Hypersensitivity
7 (.3%)
Epstein-barr Virus Infection
7 (.3%)
Erythema Multiforme
7 (.3%)
Gastroenteritis
7 (.3%)
Grand Mal Convulsion
7 (.3%)
Headache
7 (.3%)
Hypophagia
7 (.3%)
Klebsiella Infection
7 (.3%)
Liver Function Test Abnormal
7 (.3%)
Lung Infiltration
7 (.3%)
Mental Status Changes
7 (.3%)
Myalgia
7 (.3%)
Neutropenia
7 (.3%)
Pharyngeal Oedema
7 (.3%)
Rash
7 (.3%)
Respiratory Distress
7 (.3%)
Rhabdomyolysis
7 (.3%)
Sinus Bradycardia
7 (.3%)
Syncope
7 (.3%)
Tremor
7 (.3%)
Tuberculosis
7 (.3%)
Upper Respiratory Tract Infection
7 (.3%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Hydrocortisone Sodium Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Hydrocortisone Sodium Succinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Hydrocortisone Sodium Succinate

What are the most common Hydrocortisone Sodium Succinate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Hydrocortisone Sodium Succinate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Hydrocortisone Sodium Succinate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Hydrocortisone Sodium Succinate According to Those Reporting Adverse Events

Why are people taking Hydrocortisone Sodium Succinate, according to those reporting adverse events to the FDA?

Premedication
763
Prophylaxis
112
Drug Use For Unknown Indication
86
Asthma
69
Product Used For Unknown Indication
65
Prophylaxis Of Nausea And Vomiting
23
Show More Show More
Ill-defined Disorder
22
Adrenal Insufficiency
18
Hypersensitivity
18
Allergy Prophylaxis
17
Crohns Disease
16
Acute Myeloid Leukaemia
15
Septic Shock
15
Pyrexia
14
Acute Lymphocytic Leukaemia
14
Sepsis
13
Urticaria
13
Rash
11
Infection
8
Steroid Therapy
8
Facial Palsy
7
Drug Hypersensitivity
7
Prophylaxis Against Graft Versus Ho...
7
Anaphylactic Reaction
7
Respiratory Disorder
7
Shock
7
Anaphylaxis Prophylaxis
6
Respiratory Therapy
6
Pain
6
Rheumatoid Arthritis
6
Colitis Ulcerative
6
Graft Versus Host Disease
6
Burkitts Lymphoma
6
Adrenocortical Insufficiency Acute
6
Metastases To Bone
6
Interstitial Lung Disease
6
Renal Failure Chronic
6
Prostate Cancer
6
Multiple Myeloma
6
Anaphylactic Shock
5
Isolated Adrenocorticotropic Hormon...
5
Myelodysplastic Syndrome
5
Laryngeal Oedema
5
Infection Prophylaxis
5
Prophylactic Chemotherapy
5
Infusion Related Reaction
5
Stem Cell Transplant
5
Lung Infection
5
Erythema
4
Temporal Arteritis
4
Analgesic Therapy
4

Drug Labels

LabelLabelerEffective
Solu-cortefCardinal Health16-MAY-12
Solu-cortefPharmacia and Upjohn Company25-JUL-12
Solu-cortefPharmacia and Upjohn Company14-AUG-12
Solu-cortefCardinal Health15-MAR-13
Solu-cortefCardinal Health23-APR-13

Hydrocortisone Sodium Succinate Case Reports

What Hydrocortisone Sodium Succinate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Hydrocortisone Sodium Succinate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Hydrocortisone Sodium Succinate.